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A Transgenic Mouse for Imaging Caspase-Dependent
Apoptosis within the Skin
Divya Khanna1,6, Christin A. Hamilton1,6, Mahaveer S. Bhojani1, Kuei C. Lee2, Andrej Dlugosz3,
Brian D. Ross2,4,5 and Alnawaz Rehemtulla1,2,5
Apoptosis is an essential process for the maintenance of normal physiology. The ability to noninvasively image
apoptosis in living animals would provide unique insights into its role in normal and disease processes. Herein,
a recombinant reporter consisting of b-galactosidase gene flanked by two estrogen receptor regulatory
domains and intervening Asp-Glu-Val-Glu sequences was constructed to serve as a tool for in vivo assessment
of apoptotic activity. The results demonstrate that when expressed in its intact form, the hybrid reporter
had undetectable b-galactosidase activity. Caspase 3 activation in response to an apoptotic stimulus resulted in
cleavage of the reporter, and thereby reconstitution of b-galactosidase activity. Enzymatic activation of the
reporter during an apoptotic event enabled noninvasive measurement of b-galactosidase activity in living cells,
which correlated with traditional measures of apoptosis in a dose- and time-dependent manner. Using a near-
infrared fluorescent substrate of b-galactosidase (9H-{1,3-dichloro-9,9-dimethylacridin-2-one-7-yl} b-D-galacto-
pyranoside), noninvasive in vivo imaging of apoptosis was achieved in a xenograft tumor model in response to
proapoptotic therapy. Finally, a transgenic mouse model was developed expressing the ER-LACZ-ER reporter
within the skin. This reporter and transgenic mouse could serve as a unique tool for the study of apoptosis in
living cells and animals, especially in the context of skin biology.
Journal of Investigative Dermatology (2010) 130, 1797–1806; doi:10.1038/jid.2010.55; published online 1 April 2010
INTRODUCTION
Apoptosis is a highly conserved, genetically programmed cell
death process that removes unwanted or damaged cells.
Apoptosis is distinguished from necrosis based on the fact that
apoptosis results from activation of specific signaling path-
ways, which include the intrinsic and extrinsic pathways. The
extrinsic pathway involves activation of cell surface death
receptors (e.g., tumor necrosis factor (TNF) receptor super-
family, member 6 (FAS) and TNF-a receptors by their
respective ligands), whereas the intrinsic pathway is generally
mediated through mitochondrial events that lead to apoptotic
peptidase-activating factor-1 and cytochrome c-mediated
activation of the apoptotic machinery (Bhojani et al., 2003).
In either case, activation of specific effector molecules (e.g.,
caspases) culminates in cell death that can be morphologi-
cally distinguished from necrosis. Apoptotic death is gen-
erally characterized by chromatin condensation, DNA
fragmentation, blebbing of the cytoplasmic membrane and
release of apoptotic bodies, and so on (Hengartner, 2000;
Strasser et al., 2000; Bhojani et al., 2003; Nicholson and
Thornberry, 2003).
The consequence of both the extrinsic and intrinsic
apoptotic pathways is the activation of members of the
caspase family of proteases, in particular caspase 3, which in
turn can cleave a large number of intracellular substrates
(Strasser et al., 2000; Botchkareva et al., 2006). A variety of
stimuli, such as changes in the levels of growth factors, loss of
adhesion in cells, DNA damage, or activation of proapoptotic
receptors, can all initiate apoptosis (Afford and Randhawa,
2000; Botchkareva et al., 2006), and dysregulation of
apoptosis can lead to either excessive elimination of cells
or prolonged survival of cells. Thus, dysfunctional apoptosis
can have many deleterious effects resulting in pathogenesis of
various diseases such as cancer, AIDS, neurodegenerative
disorders, myelodysplastic syndromes, ischemia/reperfusion
injury, and autoimmune diseases (Kaufmann and Gores,
2000; Strasser et al., 2000; Shi, 2002; Bhojani et al., 2003;
Nicholson and Thornberry, 2003; Loro et al., 2005).
The importance of apoptosis in self-renewal within the
skin and hair in response to environmental damage, as well
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as in diseases of keratinocytes, is now becoming apparent
(Raj et al., 2006). It has been shown recently that
keratinocytes possess reversible physiological defenses
against spontaneous and UV light-induced apoptosis (Norris
et al., 1997; Pincelli et al., 1997). Similarly, human
melanocytes are protected from UV-induced apoptosis by
neurotrophic proteins (Zhai et al., 1996) secreted in a
paracrine manner by other skin cells (Yaar et al., 1994). In
contrast, loss of programmed cell death may be involved in
the development of skin cancer (Botchkareva et al., 2006).
Indeed, in UV-induced skin cancer, inactivation of transfor-
mation-related protein 53 reduces the appearance of
‘‘sunburn cells,’’ apoptotic keratinocytes that might have
incurred mutations and thus are to be eliminated (Ziegler
et al., 1994). B-cell leukemia/lymphoma-2 is a major
antiapoptotic protein (Kroemer, 1997) that is expressed in
normal keratinocytes and melanocytes (Rodriguez-Villanue-
va et al., 1995). Aberrant expression of B-cell leukemia/
lymphoma-2 has been involved in tumor development
(Fanidi et al., 1992), and changes in B-cell leukemia/
lymphoma-2 levels have been observed in melanoma
(Kanter-Lewensohn et al., 1997) and nonmelanoma (Cerroni
and Kerl, 1994; Morales-Ducret et al., 1995) skin cancers.
The ability to noninvasively image apoptosis would
provide unique insight into the pathogenesis of the disorders
referenced above. To this end, we here describe a reporter in
which fluorescence imaging can be used as a surrogate for
caspase activation, and therefore apoptosis. This reporter is
an adaptation of a bioluminescence-based reporter described
previously (Laxman et al., 2002). Owing to the lack of
resolution and dependence on cofactors such as adenosine
triphosphate when luciferase is used as a reporter, we have
modified this reporter for imaging of apoptosis using
fluorescence imaging. In this study, we describe the devel-
opment of a b-galactosidase-based reporter molecule, whose
activity is dependent on caspase-3 activity. In this reporter,
the b-galactosidase sequence is flanked by a protease
cleavage site for caspase 3 (Asp-Glu-Val-Glu) on either side
of the coding sequence, which is further fused with two
estrogen receptor regulatory domains (ER) on each end
(Laxman et al., 2002). Expression of this reporter in cells
enabled noninvasive imaging in live cells as well as in tumor
xenografts and transgenic animals, in which the reporter is
expressed in the skin using the keratin 5 (KRT5) promoter.
These transgenic animals provide the ability to image
apoptosis in a sensitive, specific, and dynamic manner, and
thus can be used to obtain unique insights into the role of
apoptosis in biology of the skin (e.g., in wound healing) as
well as in diseases of the skin (e.g., in UV light-induced DNA
damage and cellular transformation).
RESULTS
Characterization of the ER-LacZ-ER reporter
The functional basis of the ER-LACZ-ER reporter is based on
the fact that b-galactosidase is active as a tetramer. We
hypothesized that fusion of the ER domain at the amino- and
carboxyl-termini (Figure 1a) of the protein would result in a
protein, in which multimerization is stearically prevented and
thus inhibits b-galactosidase activity. Proteolytic release of
the ER domains in a caspase 3-dependent manner was
enabled by the inclusion of the Asp-Glu-Val-Glu sequence
between the ER and the b-galactosidase coding sequences,
therefore enabling functional activation of b-galactosidase
(Figure 1b) in the presence of active caspase 3 (during
apoptosis).
To validate this approach, D54 glioma cells stably
expressing the ER-LACZ-ER reporter were treated with TNF
superfamily, member 10 (TNFSF10). In untreated cells
(0 hour), the reporter was detected as a 190-kDa species
(Figure 1c), but 1 hour after TNFSF10 treatment, the 190-kDa
band dissipated with a concomitant appearance of a 150-kDa
species corresponding to b-galactosidase (110 kDa) fused to a
single ER (40 kDa). At later time points, the 110-kDa species
of free b-galactosidase was detected. Analysis of caspase 3
activation in these samples confirmed the presence of active
caspase 3 at both 1 and 2.5 hours time points.
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Figure 1. Construction and validation of the recombinant reporter molecule
ER-LACZ-ER. (a) A schematic representation of the design of the ER-LACZ-ER
reporter, in which the b-galactosidase is flanked by estrogen receptor
regulatory domain (ER) at the amino- and carboxyl-termini with an
intervening Asp-Glu-Val-Glu (DEVD) sequence. (b) The proposed mechanism
of action of the ER-LACZ-ER reporter. In its intact form, the reporter shows
minimal b-galactosidase activity due to ER-mediated stearic hindrance
preventing tetramerization of the enzyme. Activation of the reporter in the
presence of an apoptotic stimulus releases the ER from individual monomers
due to a caspase 3-dependent cleavage at the DEVD sequence, allowing for
the homodimerazation of the active b-galactosidase tetramer. (c) Western blot
analysis of tumor necrosis factor superfamily, member 10 (200 ngml1)
treated D54 glioma cells expressing the reporter showed partial cleavage
of the ER-LACZ-ER reporter at 1 hour (150 kDa) and presence of the free
b-galactosidase (110 kDa) at 2.5 hours. Appearance of active caspase 3 at
these time points was consistent with the cleavage of the reporter at the
caspase 3-dependent DEVD sequence.
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To investigate the consequence of these caspase
3-dependent cleavage events on reporter activity, b-galacto-
sidase activity was monitored in D54 cells expressing wild-
type b-galactosidase (D54/LACZ), untreated D54/ER-LACZ-
ER cells as well as TNFSF10-treated D54/ER-LACZ-ER cells.
As shown in Figure 2a, b-galactosidase activity was readily
detected in D54/LACZ cells and remained essentially un-
changed for the entire 6-hour time course, while no
significant activity was detected in the untreated D54/ER-
LACZ-ER cells. In response to TNFSF10 treatment, D54/ER-
LACZ-ER cells demonstrated a significant increase in
b-galactosidase activity at the earliest time point (2 hours),
which increased at subsequent time points (Figure 2a).
Figure 2b demonstrates that the activation of b-galactosidase
activity in D54/ER-LACZ-ER cells was dose-dependent and
that doses beyond 100 ngml1 of TNFSF10 appear saturating.
To demonstrate the use of the reporter in live cell imaging
of apoptosis, D54/ER-LACZ-ER cells were treated with
TNFSF10 and imaged at various times using DDAOG (9H-
{1,3-dichloro-9,9-dimethylacridin-2-one-7-yl} b-D-galacto-
pyranoside). DDAOG is a chromogenic substrate made
by conjugating b-galactosidase and 7-hydroxy-9H-{1,3-di-
chloro-9,9-dimethylacridin-2-one (DDAO). Cleavage of
DDAOG into DDAO by b-galactosidase produces a far-red
fluorescent signal. The cleaved substrate DDAO emits a
50 nm red shift enabling specific detection of the cleaved
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Figure 2. Activation of b-galactosidase in response to apoptosis. (a) Time-dependent activation of b-galactosidase activity in ER-LACZ-ER-expressing cells. D54
cells expressing wild-type LACZ (D54/LACZ) or the ER-LACZ-ER reporter were treated in the presence of 100 ngml1 tumor necrosis factor superfamily, member
10 (TNFSF10) or untreated (Control). At each time point, b-galactosidase activity was measured using the DDAOG (9H-{1,3-dichloro-9,9-dimethylacridin-2-
one-7-yl} b-D-galactopyranoside) substrate and live cells. (b) Activation of b-galactosidase in D54/ER-LACZ-ER cells following TNFSF10 treatment in a dose-
dependent manner. (c) Fluorescent microscopic imaging showing time-dependent activation of b-galactosidase after treatment with 200 ngml1 of TNFSF10.
The presence of the DDAOG (intact) substrate was imaged by excitation at 488 nm (pseudocolored in green), while production of the DDAO (cleaved)
product in a b-galactosidase-dependent manner was imaged by excitation at 633 nm (pseudocolored in red). Bar¼ 20 mm. (d) A dose-dependent increase in
b-galactosidase activity was determined as in panel b. Bar¼ 20 mm.
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substrate from the intact substrate (DDAOG) (Tung et al.,
2004). As shown in Figure 2c, control untreated cells (0 hour)
failed to convert any detectable levels of DDAOG to DDAO
(lack of red fluorescence), indicating the absence of
b-galactosidase activity. Low levels of DDAO were detec-
ted at the 1 hour time point, which accumulated over time.
Significant DDAO accumulation (5 and 24 hours) correlated
with the appearance of apoptotic, rounded morphology of the
D54 cells. A dose–response study (Figure 2d) confirmed the
quantitative nature of the reporter and also demonstrated that
in the absence of an apoptotic stimulus, DDAOG to DDAO
conversion was undetectable. However, in the presence of as
little as 25 ngml1 of TNFSF10, significant activity was
detected that increased with increasing doses of the apoptotic
stimulus. At the highest doses, DDAO-containing cells were
also morphologically apoptotic.
To investigate the use of the reporter in live animals,
preliminary studies were conducted, wherein D54/ER-LACZ-
ER cells were implanted subcutaneously into nude mice.
When the tumors were B100mm3 in size, treatment of the
animals with TNFSF10 resulted in a 350% increase in
fluorescence activity from DDAO production as compared
with pre-treatment levels (Figure 3a). No significant change in
the fluorescence activity was detected in control animals
treated with saline over this time interval, whereas the
TNFSF10-treated cohort of animals had significantly in-
creased fluorescence activity over the control group
(Po0.001) (Figure 3b).
Expression of ER-LACZ-ER reporter in transgenic mice
In an effort to develop a mouse model, in which apoptosis
could be monitored noninvasively and dynamically in the
skin, we constructed a transgenic mouse in which ER-LACZ-
ER reporter was driven by the keratinocyte-specific KRT5
promoter. The structure of the expression cassette is shown in
Figure 4a. Analysis of tail genomic DNA in the founders
revealed the presence of a 540 base pair sequence by PCR in
transgenic animals but not control animals (Figure 4b).
Immunohistochemical analysis of skin tissue from transgenic
animals revealed the presence of b-galactosidase immunor-
eactivity in epidermal cells, which corresponded to cells that
had KRT5-positive staining (Figure 4c, right). Control animals
failed to show b-galactosidase-specific immunoreactivity
(Figure 4c, left).
To investigate whether the reporter in the transgenic
animals was conditionally activated in response to an
apoptotic stimulus, shaved mice were UV-irradiated and
fluorescence imaging was performed upon administration of
the DDAOG substrate. No significant DDAO fluorescence
was detected in mock-treated animals, but in UV-irradiated
animals, a significant increase in DDAO fluorescence was
observed at 24 hours compared with pretreatment (Figures 5a
and b, respectively). In a cohort of five animals, a statistically
significant 1.8-fold increase in DDAO fluorescence activity
was detected over mock-irradiated animals (Figure 5c)
(Po0.001). Surgical removal of skin from nontransgenic as
well as unirradiated (transgenic CON) and UV-irradiated
(transgenic UV) transgenic animals revealed the presence
of the 190-kDa ER-LACZ-ER polypeptide in the trans-
genic animals; it was not present in the control animals
(Figure 5d). In addition, the active liberated form of the
b-galactosidase (B110 kDa) was observed in the UV-
irradiated animals and not in the unirradiated animals (Figure
5d). To validate the imaging studies, we conducted im-
munohistological studies using an antibody specific for active
caspase 3 to demonstrate the presence of apoptotic activity
within the UV-irradiated mouse skin samples. As shown in
Figure 6, no significant staining was observed in unirradiated
animals, whereas UV-treated animals had significant levels of
active caspase 3 positivity within the epidermal cells.
Finally, skin sections from an untreated control mouse and
a UV-irradiated mouse were stained using 5-bromo-4-chloro-
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Figure 3. In vivo imaging of apoptosis in D54/ER-LACZ-ER xenografts. (a) D54/ER-LACZ-ER glioma cell lines were used to generate subcutaneous tumor
xenografts. Fluorescence imaging was achieved using a Maestro imaging workstation (CRI, Woburn, MA) as described in the Materials and Methods section.
Upon DDAOG (9H-{1,3-dichloro-9,9-dimethylacridin-2-one-7-yl} b-D-galactopyranoside) administration, images were acquired before (T¼ 0hour) and
12hours (T¼12 hours) after treatment with saline (control) or tumor necrosis factor superfamily, member 10 (TNFSF10) treatment. Bar¼ 1 cm. (b) The average
percentage change in fluorescence activity in saline-treated (control) and TNFSF10-treated animals was found to be statistically different (Po0.001). Error bars
represent±SD, n¼ 5.
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3-indolyl-b-D-galadctopyranoside to identify cells that pos-
sessed both active b-galactosidase and with an antibody
specific for active caspase 3. As shown in Figure 6b,
untreated control cells had no significant staining for active
caspase 3 and low b-galactosidase activity. These results
reveal colocalization of the b-galactosidase activity with
activation of caspase 3, thus directly correlating detection of
the fluorescent signal with apoptosis using this molecular
imaging reporter system.
DISCUSSION
Two apoptotic pathways of physiological importance have
been identified in the skin. The first involves UVR in sunlight,
which is the principal carcinogen, serving as initiator and
promoter of most skin tumors (Ziegler et al., 1994). UV
radiation elicits transformation-related protein 53-dependent
apoptosis in DNA-damaged keratinocytes (sunburn cells),
presumably as a ‘‘guardian of the genome’’ response to
eradicate precancerous cells in the skin (Brash, 1996). This
transformation-related protein 53-driven response, termed
‘‘cellular proofreading’’ (Brash, 1996), eliminates damaged
cells rather than repairs damaged DNA in cells. Mice
deficient in Trp53 (Trp53-null) have reduced sunburn cell
formation and increased susceptibility to UV-induced
skin carcinogenesis (Ziegler et al., 1994; Li et al.,
1998), implicating apoptosis as a critical event in skin
Kpn I
β-Globin
540 bp
1353
1078
872
600
310
Control Transgenic
DAPI
DAPI
KRT5
β-Galactosidase DAPI β-Galactosidase
DAPI KRT5
Tra
ns
ge
nic
 +
No
ntr
an
sge
nic
pB
K5
ER
-LA
CZ
-ER
No
 te
mp
lat
e
Ma
rke
r
Not I Not I Kpn I
BssH II
Poly AER-LACZ-ER
BssH II
KRT5 promoter
Figure 4. Transgenic mouse model for skin-specific expression of the ER-LACZ-ER reporter. (a) Schematic representation of the transgenic construct containing
the ER-LACZ-ER coding sequence under the transcriptional control of the keratin 5 (KRT5) promoter. (b) Presence of the transgene was determined by
PCR analysis. Tail-derived genomic DNA from transgenic animals (Transgene þ ) yielded a 540-bp band, whereas nontransgenic animals did not yield a
corresponding band. A plasmid containing the transgenic cassette was used as a positive control (pBKER-LACZ-ER) and water (no template) as a negative control.
(c, d) Immunohistochemical analysis of formalin-fixed, paraffin-embedded dorsal skin sections from nontransgenic (control) and transgenic mice (ER-LACZ-ER
transgenic). Presence of b-galactosidase protein and KRT5 was detected using the appropriate antisera. DAPI (4,6-diamidino-2-phenylindole) staining was used
to identify nuclei. In control animals, KRT5 staining but not b-galactosidase staining was observed, whereas in transgenic animals, KRT5 staining and
b-galactosidase staining was detected in similar populations within the section. Bar¼ 40 mm.
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carcinogenesis. The second pathway involves activation of
the cell surface death receptor FAS. Defects in this pathway
have been associated with skin diseases, including eczyma-
tous dermatitis, toxic epidermal necrolysis, and graft-versus-
host disease (reviewed by Raj et al. (2006)).
Orchestration of the apoptotic program is critical for the
maintenance of homeostasis within the skin. The skin barrier
is composed mainly of the epidermis, which is continuously
renewed by the mitotic activity of stem cells in the basal
layer, which provides new keratinocytes. Cornification, a
programmed cell death process, involves withdrawal of
keratinocytes from the cell cycle, detachment from the
basement membrane, and terminal differentiation to become
corneocytes in the outer layers of the epidermis, providing a
critical barrier function. Imbalances in the production of
keratinocytes or the formation of the cornified epithelium can
disrupt the barrier function of the skin and are responsible for
many skin disorders. As our understanding of the role of
keratinocyte apoptosis in normal epidermal development and
in various skin diseases is primarily from studies in cultured
cells, validation of these concepts in animal models is needed
so that apoptosis-based therapeutic interventions can be
developed and validated.
In this study, we describe a mouse model in which
apoptosis can be noninvasively and quantitatively evaluated
macroscopically in live animals as well as microscopically in
tissue sections and living cells. This will enable the
translation of laboratory studies into the development of
therapeutics that modulate apoptosis with the goal of treating
diseases such as skin cancer, dermatitis, and graft-versus-host
disease. Adapting from our previously described reporter for
imaging of apoptosis using bioluminescence (Laxman et al.,
2002), we present results in this study using fluorescence
imaging as a readout of b-galactosidase activity that validate
the specificity, sensitivity, as well as noninvasive quantitative
nature of the reporter.
KRT5 is expressed in the basal layer of proliferating
keratinocytes within the multilayered epithelia (Ramirez
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Figure 5. Imaging of UV-induced apoptosis in transgenic animals. Transgenic mice were shaved and UVB-irradiated (b) or mock irradiated (a). The irradiated
area is outlined as a red square. After irradiation, mice were injected with the fluorescent substrate DDAOG (9H-{1,3-dichloro-9,9-dimethylacridin-2-one-7-yl}
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et al., 1994). Using the KRT5 minimal promoter fragment, we
derived transgenic mice in which the above described
apoptosis reporter was expressed in a tissue-specific manner.
Using a KRT5-specific antibody and b-galactosidase-specific
antibody, we demonstrate here that the reporter was
expressed within the basal layer of the epidermis and the
outer root sheath of the hair follicles (Figure 4). The
importance of this proliferating layer in UV-induced apopto-
sis was confirmed by immunostaining with an active caspase
3-specific antibody that showed localization to these cellular
layers (Figure 6a); moreover, staining for active caspase 3
colocalized with cells in which active b-galactosidase
activity was also present (Figure 6b). These results were
further confirmed by western blot analysis of ex vivo tissue
samples in which the ER-LACZ-ER reporter was expressed
predominantly as an intact 190-kDa polypeptide in control
animals, whereas significant cleavage of the reporter resulted
in the 110-kDa active form of b-galactosidase (Figure 5).
The sensitivity and specificity of the reporter was studied in
cultured cells, and it was revealed that the reporter was able to
detect levels of caspase 3 activity that were below what is
required to induce phenotypic changes within cells. For
example, as shown (Figure 2c, d), at 1 and 2.5hours after
TNFSF10 treatment, a major fraction of the cells appeared
normal and lacked morphological features of apoptosis, but
fluorescence imaging using lysed cells (Figure 2a) and live cells
(Figure 2c) detected a significant change in b-galactosidase
activity. Similarly, at 25ngml1 of TNFSF10 (Figure 2b and d),
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Figure 6. Generation of active caspase 3 within proliferating cells of the skin. (a) Immunohistological studies showing presence of active caspase 3 within the
UV-treated transgenic samples (bottom) and not in mock-irradiated (control) animals (top). Proliferating populations within the skin including the basal layer of
the epidermis and the outer root sheath of the hair follicles (arrows) had the highest levels of active caspase 3. Bar¼ 40mm. (b) Correlation of caspase 3 positivity
and b-galactosidase activity. Cryosections of unirradiated (control) and UV-irradiated transgenic animals were stained with 5-bromo-4-chloro-3-indolyl-b-D-
galadctopyranoside (X-gal) and an antibody specific for activated caspase 3. Colocalization of b-galactosidase activity and active caspase 3 staining was
observed within the epidermal cells of treated animals (shown by arrows) but not in the control animals. Bar¼ 40mm.
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morphologically the cells appeared normal, but significant
b-galactosidase activity was detected in cell extracts and in
live cells.
The fact that this transgenic mouse model has expression
of a sensitive and quantitative reporter within the crucial
cellular populations of the skin that has a key role in the
biology of the skin suggests that this model will be invaluable
for studies delineating the role of apoptosis in a variety of skin
diseases as well as in the development and testing of
therapeutic interventions for these diseases. Homeostasis
between proliferation and apoptosis is crucial for optimal
architecture of the skin and maintenance of epidermal barrier
function. Although cornification of keratinocytes is morpho-
logically indistinguishable from the morphological features
observed in traditional programmed cell death (Lippens et al.,
2009), it is interesting that in the transgenic mouse expressing
the reporter for caspase 3-dependent apoptosis, no significant
activation of the reporter was observed in non-stimulated
skin. This observation is consistent with mounting evidence
that caspases 3, 6, 7, and 9 may not be involved in epidermal
differentiation leading to cornication (Lippens et al., 2009).
Mice lacking these caspases have essentially normal skin
development. In contrast, mice lacking caspase 14, a skin-
specific zymogen protease, has been implicated in skin
development, as mice lacking this protein have defective
corneum formation (Denecker et al., 2007). Modification of
the reporter described here, so that it can be activated in a
caspase 14-dependent manner, would be a valuable tool in
the study of skin morphogenesis.
In conclusion, mouse models provide many opportunities
to improve our understanding of the basic biology and
underlying molecular mechanisms involved in the dynamic
processes associated with skin injury and repair. A key
component of cellular response to stress is the activation of
the apoptotic machinery. To this end, we have developed a
transgenic mouse model in which fluorescence activity of the
skin was dependent on activation of caspase 3. Fluorescent
activity after TNFSF10 treatment and UVR exposure was
shown to be dose- and time-dependent and correlated
directly with caspase 3 activation. Temporal evaluation of
caspase 3 activity was shown to be possible by revealing the
potential for using this molecular imaging reporter for a wide
variety of studies; for example, involving pretreatment with
UV-modifying agents. Overall, this study reports on the
development and validation of a genetically engineered
molecular imaging reporter construct for the detection of
apoptosis in the skin of genetically engineered mice.
MATERIALS AND METHODS
Construction of hybrid molecules
All methods in this paper were approved by the Medical Ethical
Committee at the University of Michigan. Briefly, two versions of the
b-galactosidase molecule were cloned into pEF vector. The first
consisted of wild-type b-galactosidase (pEFLacZ) and the second was
chimeric fusion gene pEFERLACZER, which harbored sequences
from ER (residues 281–599 of the mouse ER) at both the amino- and
the carboxy-termini of the b-galactosidase with the Asp-Glu-Val-Glu
sequence intervening the two domains on either side. The coding
sequences (see Supplementary Figure S1 online) were cloned into
the expression vector pEF, which drives transcription of the inserted
coding sequence by using the elongation factor-1a promoter with
the neomycin-resistance gene as bicistronic message.
Cell culture, transfection, and treatments
D54 (human glioma) cells were grown in RPMI 1640 medium
supplemented with 10% fetal bovine serum, 100Uml1 penicillin,
100mgml1 streptomycin sulfate, 1mM sodium pyruvate, 10mM
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 292 mgml1
L-glutamine (all from Invitrogen, Carlsbad, CA) and maintained in
a humidified incubator at 37 1C and 5% CO2. The constructs
described above were transfected into D54 (human glioma) cells
using Fugene (Roche Diagnostic Corporation, Indianapolis, IN), and
the stable clones were selected using 0.2mgml1 G418 (Invitrogen)
and characterized for expression of the reporter by western blot
analysis using total cell lysates. Specific clones were identified and
selected for further study on the basis of the expression levels of the
recombinant protein. Purification of TNFSF10 was described else-
where (Chinnaiyan et al., 2000). Treatments of cells with TNFSF10
were previously described in the study by Laxman et al. (2002).
In vitro activation of caspase 3 in reporter expressing D54 cells was
achieved by treating cells with 200 ngml1 TNFSF10.
In vitro activation of DDAOG
Reporter activation was measured by using the substrate DDAOG
(Invitrogen), which upon cleavage produces a shifted far-red
fluorescence (Tung et al., 2004). To measure cellular activation of
DDAOG by b-galactosidase, D54, D54/LACZ, and D54/ER-LACZ-
ER cells were seeded in 12-well plates at 75,000 per well and
175,000 cells per well for approximately for 16 hours. Cells were
washed three times with HBSS (Hank’s Balanced Solution) and then
treated with 100 ngml1 of TNFSF10. Following TNFSF10 treatment,
DDAOG was added directly to the live cells at a final concentration
of 10 mM. After incubation, the fluorescence signal was measured
using a FLUOstar OPTIMA fluorescent plate reader (BMG Labtech,
Cary, NC) with a 610 excitation filter and a 650 emission filter. By
exciting at a wavelength greater than 600 nm, only the cleaved
substrate (DDAO) was excited and measured (Tung et al., 2004).
Fluorescence imaging in vitro
Detailed cellular activation of DDAOG was monitored using a
confocal microscope (Nikon D-Eclipse C1, Nikon Instruments,
Melville, NY). D54, D54/LACZ, and D54/ER-LACZ-ER cells were
grown on 25mm glass coverslips in six-well plates to 80%
confluency. First the cells were treated with TNFSF10 as specified
and then incubated with DDAOG (10mM) for 30minutes at 37
degrees in HBSS. Floating cells were collected and washed three
times with HBSS along with the coverslips. Confocal microscopy
was performed with a Nikon D-Eclipse C1 3 Laser unit module
(Spectra Physics, Santa Clara, CA, Argon 488, Green He-Ne 543,
Red He-Ne 633). The argon 488 laser was used to visualize
uncleaved DDAOG, and the Red He-Ne 633 laser was used to
visualize cleaved substrate.
Fluorescence imaging in vivo of D54/ER-LACZ-ER xenografts
Subcutaneous tumors expressing D54/ER-LACZ-ER were established
by implanting 1 107 stably transfected cells subcutaneously on the
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dorsal surface of the skull in athymic-nude mice (CD-1-Foxn1nu/
Foxn1nu, Charles River Laboratory, Portage, MI). Tumors were
allowed to grow to 100mm3 in size, at which point the experiment
was initiated. Before imaging, animals were anesthetized using a
mixed solution of ketamine (90mg kg1) and xylazine (10mg kg1)
given through intraperitoneal injection. The fluorescent substrate
DDAOG (0.5mg) was then injected intravenously in a vehicle
solution (100 ml) comprising of dimethylsulfoxide and phosphate-
buffered saline (1:1), and fluorescence imaging was performed
approximately 15–20minutes after injection of substrate. Near-
infrared reflectance imaging was performed using the Maestro
system (CRI, Woburn, MA) at 0 and 12 hours time points (Tung et al.,
2004) in control and treated animals. The excitation and emission
filters were set at 640 and 700 nm, respectively. The acquired images
were then analyzed and quantified using the software package
included in the CRI system. Signal levels were normalized on the
basis of the background fluorescence levels on the skin by manually
placing regions of interest. After normalization, the change in signal
from each animal, using the same regions of interest for pretreatment
and treatment scans, was then calculated. All mouse experiments
were approved by the University Committee on the Use and Care of
Animals (UCUCA) of the University of Michigan.
PCR amplification of the transgene
The ER-LACZ-ER transgene was amplified using the Expand Long
Template PCR kit (Roche Diagnostics, Indianapolis, IN). The primer
pair used for amplification was ERF (50-AAGGAAAAAAGCGGCCG
CATGGGTGCTTCAGGAGAC) and ERR (30-TTTTTTCCTTGCGGCC
GCTCATCAGATCGTGTTGGGGAA). The 5.2-kb product was puri-
fied using the Qiagen PCR Purification Kit (Qiagen, Valencia, CA).
Transgenic animals
All animals were cared for using protocols approved by the
University Committee for the Use and Care of Animals. The pBK5
vector cassette containing the KRT5 promoter was kindly provided
by the Dlugosz lab (University of Michigan, Ann Arbor, MI).
A Not1 PCR fragment containing the ER-LACZ-ER cDNA was
inserted into the polylinker of the vector pBK5 that contained the
5.2-kb bovine KRT5 regulatory sequences, b-globin intron 2, and
the 30-polyadenylation sequences. The ER-LACZ-ER transgene was
excised from the pBK5ER-LACZ-ER cassette using Ase1. The transgene
was purified and was used to generate transgenic animals at the
Transgenic Animal Core (Van Andel Institute, Grand Rapids, MI)
by microinjection of B6C3F2 oocytes. Transgenic ER-LACZ-ER
expression was characterized using standard PCR techniques with
primers specific for b-galactosidase (50LacZ, GCCTGCGATGTCGGT
TTCCGCGAG and 30LacZ, CGCGCGTACATCGGGC). A total of three
distinct founder lines were obtained and inbred for five generations.
To obtain a white background, all three founder lines were then
crossed with FVB/N mice for at least three generations. All experi-
ments were performed using these animals that were inbred five
generations followed by mating with FVB/N for at least three
generations or more and were aged between 6 and 14 weeks.
Activation and measurement of apoptosis in vivo using UVB
Patches (1 1 cm) on the dorsal skin of 2- to 6-week-old mice
were depilated using Nair, Princeton, NJ. After 24 hours, the exposed
dorsal skin patches were irradiated at a dose of approximately
600 Jm2 using a UVB lamp (FS20T12-UVB, National Biological,
Twinsburg, OH), ensuring that no other portion of the mouse
was exposed to radiation. According to the manufacturer, this UVB
bulb emitted wavelengths between 250 and 420nm, with peak
emission at 313 nm. The intensity of the UV light source was
measured before each experiment using a UVX radiometer
(UV, Torrance, CA). The following day, mice were anesthetized,
injected with DDAOG (0.5mg kg1) substrate 15–20minutes before
imaging (details described above). Fluorescence activity was
measured using the IVIS imaging system (Caliper, Hopkinton, MA)
at 0 and 12 hours time points. The excitation and emission filters
were set at 610 and 650nm, respectively. Fluorescence imaging was
performed using the Living Image 3.0 software (Caliper, Hopkinton,
MA) and images were acquired after a 2-minutes exposure. Signal
background levels were measured by manually placing regions of
interest (p200 pixels) within the visible tumor margins and the
adjacent skin.
Western blot analysis
Briefly, the mice were killed and protein extracts were prepared by
homogenizing shaved skin in RIPA Buffer using a plastic homo-
genizer. A quantity of 40 ml of the crude extract was separated on
Novex 4–20% Tris-Acetate SDS-PAGE gel (Invitrogen, Carlsbad, CA)
and transferred to nitrocellulose membrane. The membranes
were blocked in 5% milk prepared in TBS-T and probed with
b-galactosidase rabbit IgG fraction (Invitrogen) and rabbit anti-actin
(Sigma-Aldrich, St Louis, MO). The secondary rabbit polyclonal
antibody (Sigma, St Louis, MO) was conjugated to horseradish
peroxidase and the transgene was detected by chemiluminiscent
horseradish peroxidase substrate.
Immunohistochemistry analysis and 5-bromo-4-chloro-3-
indolyl-b-D-galadctopyranoside staining
Immunohistochemical staining of formalin-fixed, paraffin-embedded
epidermis samples (prepared by University of Michigan Comprehensive
Cancer Center Tissue Core, MI) was performed using polyclonal rabbit
anti-mouse KRT5 (Covance, Berkeley, CA) and anti-b-galactosidase
rabbit IgG fraction (Molecular Probes, Eugene, CA). The reactions were
visualized with goat anti-rabbit IgG labeled with Cy3 and Cy5. For
active caspase 3 and 5-bromo-4-chloro-3-indolyl-b-D-galadctopyr-
anoside immunostaining, cryosections of the skin tissue were
prepared using a CryoJane (Electron Microscopy, Halfield, PA),
and the tissue was stained using an active caspase 3 antibody and the
b-galactosidase staining kit (Invitrogen). The samples were analyzed
using a confocal microscope (Nikon).
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